Joyance Partners, investor in femtech companies like Attn: Grace, Rosy, Expectful, She’s Well, Unbound, and AOA Dx, has announced a new early-stage fund to invest in science centered companies that help people live longer, better, or both. The new fund’s investments will focus on 4 key outcomes, across 4 primary fields, driven by 4 science and technology vectors.
“This layered structure allows us to remain focused but still continue to change and grow as the venture landscape adapts to new challenges in health and happiness,” explains Mike Edelhart, Managing Partner at Joyance Partners in a blog post. “Health is poised to undergo a fundamental worldwide shift away from disease response and Big Medicine, toward prevention and agency for the individual. We feel that the desire for happiness will propel health choices people make and vice versa. We intend to be foundational to that transformation in our new fund, SH².”
The fund plans to focus on the following industries and verticals:
Health
- Mental Health
- Neuroscience
- Women’s Health
- Chronic Care
- Precision Medicine
- Behavioral Change
- Microbiome
Happiness
- Inner, Local, & Public Space
- New Modes for Learning
- Emergent Communities
- Immersive Experience
- Lab Grown & Plant-Based Meats
- Food & Drink Innovation
- Cosmetics & Beauty & Fashion
- Fitness & Physical Activity
- Pets
- Preventative Healthcare
- Next Gen Food/Drink
- Senses – Olfactory, Gustation, Tactile, Hearing, Vision
Emerging Areas
- Synthetic Biology
- New Modes of Entertainment
- Personal Control of Energy
